1. Preparation, Characterization and In vitro Evaluation of Insulin-PHBV Nanoparticles/Alginate Hydrogel Composite System for Prolonged Delivery of Insulin.
- Author
-
Bayrami S, Chamani M, JamaliMoghadamSiahkali S, SeyedAlinaghi S, Shirmard LR, Bayrami S, Javar HA, Ghahremani MH, Amini M, Tehrani MR, Shahsavari S, and Dorkoosh FA
- Subjects
- Animals, Mice, Cell Line, Glucuronic Acid chemistry, Hexuronic Acids chemistry, Drug Delivery Systems methods, Drug Carriers chemistry, Drug Liberation, Hypoglycemic Agents administration & dosage, Hypoglycemic Agents chemistry, Hypoglycemic Agents pharmacokinetics, Hypoglycemic Agents pharmacology, Polyhydroxybutyrates, Alginates chemistry, Insulin administration & dosage, Insulin chemistry, Hydrogels chemistry, Nanoparticles chemistry, Cell Survival drug effects, Polyesters chemistry, Delayed-Action Preparations chemistry
- Abstract
Purpose: In the present study, biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles (NPs) containing insulin were loaded in sodium alginate/jeffamine (ALG/jeff) hydrogel for prolonged delivery of insulin. The main aim of this work was to fabricate an efficient insulin delivery system to improve patient adherence by decreasing the repetition of injections., Methods: Swelling and morphological properties and crosslinking efficiency of ALG/jeff hydrogel were assessed. The composite hydrogel was prepared by adding PHBV NPs to ALG/jeff hydrogel concurrently with crosslinking process. The morphology and loading capacity of composite hydrogel were analyzed., Results: Circular dichroism measurement demonstrated that insulin remains stable following fabrication process. The release profile exhibited 54.6 % insulin release from composite hydrogel within 31 days with minor initial burst release equated to nanoparticles and hydrogels. MTT cell viability analysis was performed by applying L-929 cell line and no cytotoxic effect was observed., Conclusions: Favorable results clearly introduced fabricated composite hydrogel as an excellent candidate for drug delivery systems and also paves the route for prolonged delivery systems of other proteins., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF